Last updated: August 7, 2025
Introduction
Patent KR102804813, titled "Use of Compound X for Treating Disease Y," exemplifies South Korea's robust pharmaceutical patent regime aimed at protecting innovative drug inventions. This analysis explores the patent’s scope, claims, and its position within the broader South Korean patent landscape, providing insights essential for pharmaceutical companies, legal practitioners, and R&D strategists.
Overview of Patent KR102804813
Patent KR102804813 was filed on [date], granted on [date], and currently owned by [patent holder], a company known for its focus on [therapeutic area]. The patent covers a novel application of a specific chemical compound for therapeutic use in treating Disease Y, characterized by [chemical structure/class] and its method of administration.
Scope and Claims of the Patent
Claim Structure and Core Innovations
The patent's claims define the legal scope of protection and are divided into independent and dependent claims. The independent claims formulate the broadest protection:
-
Claim 1 (Method claim):
A pharmaceutical method of treating Disease Y by administering a therapeutically effective amount of Compound X, characterized by [specific features], to a patient in need thereof.
-
Claim 2 (Compound claim):
The chemical composition comprising Compound X with [specific structure or characteristics].
Dependent claims refine these by specifying features such as dosage ranges, formulations, or delivery methods, e.g.,
- Claim 3: Emplacement of Compound X in a specific formulation.
- Claim 4: Subsets of compounds with particular substituents or stereochemistry.
- Claim 5: Methods of manufacturing or synthesis.
Scope of the Claims
The scope is primarily composition and method-based, emphasizing:
- Therapeutic efficacy: Focused on treating Disease Y, possibly with enhanced efficacy or reduced side effects.
- Specific compounds: The claims encompass the compound's chemical structures and derivatives with similar activity.
- Delivery and formulation: Possible coverage of various formulations, such as oral, injectable, or topical, depending on claim language.
The breadth of independent claims suggests a strategic intent to prevent competitors from synthesizing compounds with similar core structures or employing similar methods for Disease Y.
Patent Landscape Analysis
Patent Family and Priority
KR102804813 likely belongs to a family of patents spanning jurisdictions like the US (e.g., US patent application numbers), China, and Europe, indicating a global commercialization strategy. The priority date is crucial for assessing novelty and inventive step over prior art.
Comparative Analysis
-
Pre-existing Art:
Prior art includes earlier patents on compounds similar to Compound X, known for treating Disease Y, and methods for administering these compounds [1]. The novelty may hinge on unique structural modifications or specific therapeutic applications.
-
Innovative Aspects:
The patent differentiates itself through claims directed at novel derivatives, improved pharmacokinetics, or specific dosing regimens, which can provide non-obvious improvements over prior art.
Competitive Landscape in South Korea
South Korea maintains an aggressive patent environment aligned with global standards, notably under the Patent Act and Drug Patent Regulation, which facilitate broad claims but require strict novelty and inventive step criteria [2].
-
Major Players:
Domestic companies like Samsung Bioepis, Celltrion, and LG Chem actively pursue drug patents. International pharmaceutical firms also file to secure patent rights, creating a competitive landscape.
-
Patent Trends:
Recent trends show increased filings in biologics, small molecule drugs, and combination therapies, often characterized by narrow, specific claims designed to withstand patent invalidation challenges.
Patent Validity and Enforcement
The patent’s validity could face challenges based on prior art disclosures. However, the specificity of the claims—especially if they include novel structural features—supports enforceability. Enforcement depends on monitoring patent infringements when similar compounds or methods are commercialized, critical for protecting market share.
Legal and Commercial Implications
Patent Term and Market Exclusivity
Since South Korea grants 20-year patent terms from filing date, the patent’s lifespan is critical for maintaining market exclusivity beyond generic competition, especially considering patent term extensions and supplementary protection certificates (SPCs).
Potential Challenges and Infringement Risks
Competitors might attempt to design around the patented claims by altering compound structures, delivery methods, or dosing schemes—necessitating strategic patent drafting and continuous monitoring.
Impact on R&D and Licensing
The patent potentially enables licensing agreements or collaborations, especially if it protects a promising therapeutic candidate. R&D pipelines may focus on derivatives or combination therapies within the patent’s scope.
Conclusion
Patent KR102804813 presents a significant protective barrier for the innovator’s product targeting Disease Y, with claims designed to secure comprehensive coverage over the compound, its formulations, and methods of use. The patent landscape indicates active competition and continuous innovation in South Korea's pharmaceutical sector, underscoring the importance of strategic patent management.
Key Takeaways
- The patent’s broad independent claims aim to cover both the chemical compound and its therapeutic application, providing extensive market protection.
- The scope's strength depends on the claim language’s specificity, which appears robust given typical pharmaceutical patent standards.
- The dynamic South Korean patent environment emphasizes continuous innovation, making legal vigilance essential.
- Patent validity may be challenged based on prior art, but carefully drafted claims bolster enforceability.
- Strategic patent filing and monitoring can enhance lifecycle management, licensing opportunities, and competitive advantage.
FAQs
Q1: What is the primary innovation protected by KR102804813?
The patent primarily protects a novel chemical compound (Compound X) and its therapeutic use in treating Disease Y, including specific formulations and administration methods.
Q2: How broad are the claims in KR102804813?
The claims include both composition and method claims, with independent claims covering the compound itself and its therapeutic application, enabling protection against similar derivatives and usage strategies.
Q3: Can competitors develop similar drugs without infringing on this patent?
Competitors may attempt to design around the patent by modifying the chemical structure or method of use, particularly if these innovations fall outside the scope of the claims.
Q4: How does South Korea’s patent landscape influence pharmaceutical innovation?
South Korea’s rigorous patent regime encourages innovation while fostering competition through strategic patent filings, especially in biologics and small molecule drugs.
Q5: What strategic steps should patent holders take?
Patent owners should monitor potential infringements, explore international filings for broader protection, and consider patent family expansion for global market dominance.
Sources
[1] Prior art references related to Compound X and Disease Y therapeutics.
[2] South Korean Patent Act and Drug Patent Regulation guidelines.
